Tag: Liver
113-Gene Signature May Predict Long-Term HCC Risk in NAFLD
Prognostic liver signature validated in cohorts of patients with NAFLD, with and without history of hepatocellular carcinoma
Sugar-Sweetened Drinks May Raise Risk for Liver Cancer
Hazard ratio of 1.78 for consumption of one or more SSB/day compared with never consumption for older women
Radiation Segmentectomy Efficacious for Unresectable Liver Cancer
All patients had initial objective response and 90 percent had sustained complete response; few patients had high-grade adverse events
Black Seniors With GI Malignancy More Likely to Be Frail
Black patients also more likely to report limitations in daily living, instrumental activities of daily living
Combo Immunotherapy Ups Survival in Advanced Liver Cancer
Overall survival, but not progression-free survival, improved with tremelimumab plus durvalumab versus sorafenib for unresectable HCC
Guideline Issued for External Beam RT in Primary Liver Cancers
EBRT strongly recommended as potential first-line therapy for patients with HCC confined to liver who are not candidates for curative therapy
Higher Serum Iron May Up Liver Cancer Risk in NAFLD Patients
Increased risk for hepatocellular carcinoma also seen with higher transferrin saturation levels in patients with nonalcoholic fatty liver disease
Urban-Rural Disparity Seen in New Liver Cancer Cases
Incidence of liver cancer rising at an annual rate of 5.7 percent in rural areas
More Frequent Alcohol Consumption Ups Risk for GI Cancers
Amount of alcohol consumed in each occasion seems to be a less important risk factor
Mortality Risk Up for Fragmented Care After Complex Cancer Surgery
Mortality higher for patients readmitted to outside hospital rather than index hospital after hepatopancreatobiliary or gastric cancer surgery
